— Know what they know.
Not Investment Advice

INGN NASDAQ

Inogen, Inc.
1W: +6.6% 1M: +31.1% 3M: +10.9% YTD: +7.5% 1Y: -18.7% 3Y: +59.9% 5Y: -82.9%
$7.13
+0.05 (+0.71%)
 
Weekly Expected Move ±8.4%
$6 $7 $7 $8 $8
NASDAQ · Healthcare · Medical - Devices · Tech Score Buy · Power 67 · $189.2M mcap · 23M float · 1.22% daily turnover · Short 41% of daily vol
Credit Risk of going bust: lower than 69% of companies Debt: 7.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.06 (down 99.2%), Inogen, Inc. would be worth roughly what it owes.
Total debt $15.8M against a stock market value of $189.2M.
Distance to default 7.46 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $7.9M (short-term plus half of long-term), stock volatility 44.1%; Altman Z 1.57. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$299M +0.8% ▲
5Y CAGR: -8.4%
Total Liabilities
$106M -13.0% ▼
5Y CAGR: -1.1%
Shareholders Equity
$192M +10.6% ▲
5Y CAGR: -11.3%
Cash & Investments
$120M +5.1% ▲
5Y CAGR: -12.4%
Total Debt
$17M -9.9% ▼
5Y CAGR: +11.8%
Net Debt
-$86M +8.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$236M$187M$125M$114M$104M
Short-Term Investments$10M$0$3M$0$16M
Cash & ST Investments$246M$187M$128M$114M$120M
Net Receivables$26M$64M$43M$30M$39M
Inventory$32M$34M$22M$25M$26M
Other Current Assets$0$19M$14M$17M$14M
Total Current Assets$329M$305M$207M$185M$198M
Property, Plant & Equip.$64M$65M$71M$63M$53M
Goodwill & Intangibles$93M$33M$45M$40M$41M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$3M$2M$4M$8M$6M
Total Non-Current Assets$160M$100M$119M$111M$100M
Total Assets$490M$405M$326M$296M$299M
— Liabilities —
Accounts Payable$10M$18M$13M$17M$29M
Short-Term Debt$0$0$0$0$3M
Deferred Revenue$9M$9M$8M$7M$6M
Other Current Liabilities$6M$8M$20M$23M$25M
Total Current Liabilities$62M$65M$72M$77M$64M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$23M$12M$14M$16M$18M
Total Non-Current Liabilities$58M$42M$49M$46M$43M
Total Liabilities$119M$108M$121M$122M$106M
— Equity —
Common Stock$23K$23K$23K$24K$27K
Retained Earnings$69M-$14M-$117M-$153M-$176M
Accumulated OCI$1M-$243K$1M-$2M$4M
Total Stockholders Equity$370M$297M$205M$174M$192M
Total Liabilities & Equity$490M$405M$326M$296M$299M
— Key Metrics —
Total Debt$27M$23M$22M$19M$17M
Net Debt-$209M-$164M-$104M-$94M-$86M
Total Investments$10M$0$3M$0$16M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms